Cornely OA - Search Results

1

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.

Maertens J, Selleslag D, Heinz WJ, Saulay M, Rahav G, Giladi M, Aoun M, Kovanda L, Kaufhold A, Engelhardt M, Cornely OA, Herbrecht R, Ullmann AJ. Maertens J, et al. Among authors: cornely oa. Mycoses. 2018 Nov;61(11):868-876. doi: 10.1111/myc.12831. Epub 2018 Aug 13. Mycoses. 2018. PMID: 30035825 Clinical Trial.

2

[Antifungal prophylaxis in neutropenic patients].

Cornely OA, Ullmann AJ, Karthaus M. Cornely OA, et al. Wien Med Wochenschr. 2001;151(3-4):73-9. Wien Med Wochenschr. 2001. PMID: 11789422 Review. German.

3

Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.

Ullmann AJ, Heussel CP, Cornely OA. Ullmann AJ, et al. Among authors: cornely oa. N Engl J Med. 2002 May 30;346(22):1745-7; author reply 1745-7. N Engl J Med. 2002. PMID: 12041526 No abstract available.

4

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.

Cornely OA, Ullmann AJ, Karthaus M. Cornely OA, et al. Blood. 2003 May 1;101(9):3365-72. doi: 10.1182/blood-2002-05-1356. Epub 2002 Aug 29. Blood. 2003. PMID: 12393455 Free article. Review.

5

Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.

Cornely OA, Wicke T, Seifert H, Bethe U, Schwonzen M, Reichert D, Ullmann AJ, Karthaus M, Breuer K, Salzberger B, Diehl V, Fätkenheuer G. Cornely OA, et al. Int J Hematol. 2004 Jan;79(1):74-8. doi: 10.1007/BF02983537. Int J Hematol. 2004. PMID: 14979482 Clinical Trial.

6

Itraconazole versus fluconazole for antifungal prophylaxis.

Karthaus M, Cornely OA, Ullmann AJ. Karthaus M, et al. Among authors: cornely oa. Ann Intern Med. 2004 Apr 6;140(7):579-80; author reply 581-2. doi: 10.7326/0003-4819-140-7-200404060-00026. Ann Intern Med. 2004. PMID: 15068991 No abstract available.

7

[Current development in the diagnostics and therapy of systemic fungal infections in cancer patients].

Karthaus M, Ullmann AJ, Cornely OA. Karthaus M, et al. Among authors: cornely oa. Wien Med Wochenschr. 2004 May;154(9-10):199-208. doi: 10.1007/s10354-004-0066-z. Wien Med Wochenschr. 2004. PMID: 15244045 German.

8

[Opportunistic infections after treatment with monoclonal antibodies].

Cornely OA, Ullmann AJ, Karthaus M. Cornely OA, et al. Wien Med Wochenschr. 2004 May;154(9-10):209-17. doi: 10.1007/s10354-004-0067-y. Wien Med Wochenschr. 2004. PMID: 15244046 Review. German.

9

[Vaccination of the immunocompromised host].

Ullmann AJ, Karthaus M, Cornely OA. Ullmann AJ, et al. Among authors: cornely oa. Wien Med Wochenschr. 2004 May;154(9-10):218-25. doi: 10.1007/s10354-004-0068-x. Wien Med Wochenschr. 2004. PMID: 15244047 Review. German.

10

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Walsh TJ, et al. Among authors: cornely oa. N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446. N Engl J Med. 2004. PMID: 15459300 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

664 results

Search Page

Filters